Belarus vs Early-demographic dividend: Immunization, measles second dose
Belarus
98.0%
in 2024
Early-demographic dividend
83.3%
in 2024
Belarus rank
15th
Early-demographic dividend rank
17th
Immunization, measles second dose over time
- Belarus
- Early-demographic dividend
How they compare
Belarus currently reports 98.0% against 83.3% in Early-demographic dividend, a difference of 14.7%.
That makes Belarus's figure about 1.2 times Early-demographic dividend's.
Across all 25 years both countries report, Belarus has been ahead every year.
Belarus ranks 15th and Early-demographic dividend ranks 17th of 178 countries.
Belarus has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Belarus | Early-demographic dividend | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 97.3% | 18.8% | 78.5% | Belarus |
| 2010s | 98.3% | 58.9% | 39.4% | Belarus |
| 2020s | 97.4% | 79.4% | 18.0% | Belarus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, measles second dose, Belarus or Early-demographic dividend?
- Belarus, at 98.0% against 83.3% in Early-demographic dividend as of 2024.
- What is the difference in immunization, measles second dose between Belarus and Early-demographic dividend?
- 14.7%, with Belarus ahead.
- How many years of comparable data are there for Belarus and Early-demographic dividend?
- 25 years are reported by both, from 2000 to 2024.
- How do Belarus and Early-demographic dividend rank globally for immunization, measles second dose?
- Belarus ranks 15th and Early-demographic dividend ranks 17th of 178 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, measles second dose (% of children by the nationally recommended age). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.